Neuromuscular Junction Diseases. Neuromuscular Junction Disorders . Neuromuscular Junction Toxic Disorders . Neuromuscular Transmission Disorders . Toxic Disorders, Neuromuscular Junction . Neuromuscular Junction Disease . Neuromuscular Junction Disorder . Neuromuscular Transmission Disorder . Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions. . 0.75
Neurotoxicity Syndromes. Encephalopathy, Toxic . Nervous System Poisoning . Neurotoxic Disorders . Neurotoxin Diseases . Neurotoxin Disorders . Toxic Encephalitis . Encephalitides, Toxic . Encephalitis, Toxic . Encephalopathies, Toxic . Nervous System Poisonings . Neurotoxic Disorder . Neurotoxicity Syndrome . Neurotoxin Disease . Neurotoxin Disorder . Poisonings, Nervous System . Syndrome, Neurotoxicity . Syndromes, Neurotoxicity . Toxic Encephalitides . Toxic Encephalopathies . Toxic Encephalopathy . Poisoning, Nervous System . Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents. . 0.68
Neuromuscular Agents. Neuromuscular Effect . Neuromuscular Effects . Agents, Neuromuscular . Effect, Neuromuscular . Effects, Neuromuscular . Muscle Relaxants, Skeletal . Relaxants, Skeletal Muscle . Skeletal Muscle Relaxants . Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS. . 0.65
Neuromuscular Blockade. Neuromuscular Block . Block, Neuromuscular . Blockade, Neuromuscular . The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here. . 0.63